Trial intelligence / Profile preview

DEPRIVE

2005-005524-13Phase 3Terminated

Sponsor
Crinos
Start
Jan 2006
Modality
Vaccine mRNA → mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Countries
1
01

Overview

Phase 3, randomised trial in venous thromboembolism (VTE) comparing Defibrotide with Placebo (2 arms). Started Jan 2006; status: terminated.

02

Drugs

defibrotide
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on 2005-005524-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005524-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call